Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Metolazone in acute decompensated heart failure
NCT02620384Phase 3Terminated
- Sponsor
- Aultman Health Foundation
- Start
- Oct 2015
- Primary completion
- Nov 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of metolazone in heart failure (HF), sponsored by Aultman Health Foundation. Started Oct 2015; status: terminated.
02
Drugs
metolazone
03
Conditions
heart failure (HF)
Beyond the preview
Go deeper on NCT02620384.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02620384.